| Autophagy contributes to resistance of tumor cells to ionizing radiation H Chaachouay, P Ohneseit, M Toulany, R Kehlbach, G Multhoff, ... Radiotherapy and oncology 99 (3), 287-292, 2011 | 303 | 2011 |
| Radiation-induced EGFR-signaling and control of DNA-damage repair HP Rodemann, K Dittmann, M Toulany International journal of radiation biology 83 (11-12), 781-791, 2007 | 264 | 2007 |
| Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA … M Toulany, U Kasten-Pisula, I Brammer, S Wang, J Chen, K Dittmann, ... Clinical Cancer Research 12 (13), 4119-4126, 2006 | 261 | 2006 |
| Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair M Toulany, R Kehlbach, U Florczak, A Sak, S Wang, J Chen, M Lobrich, ... Molecular cancer therapeutics 7 (7), 1772-1781, 2008 | 224 | 2008 |
| AXL mediates resistance to cetuximab therapy TM Brand, M Iida, AP Stein, KL Corrigan, CM Braverman, N Luthar, ... Cancer research 74 (18), 5152-5164, 2014 | 216 | 2014 |
| Akt promotes post-irradiation survival of human tumor cells through initiation, progression, and termination of DNA-PKcs–dependent DNA double-strand break repair M Toulany, KJ Lee, KR Fattah, YF Lin, B Fehrenbacher, M Schaller, ... Molecular Cancer Research 10 (7), 945-957, 2012 | 186 | 2012 |
| Radioresistance of K-Ras mutated human tumor cells is mediated through EGFR-dependent activation of PI3K-AKT pathway M Toulany, K Dittmann, M Krüger, M Baumann, HP Rodemann Radiotherapy and Oncology 76 (2), 143-150, 2005 | 172 | 2005 |
| Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation M Toulany, HP Rodemann Seminars in cancer biology 35, 180-190, 2015 | 170 | 2015 |
| The impact of erythrocyte age on eryptosis M Ghashghaeinia, JCA Cluitmans, A Akel, P Dreischer, M Toulany, ... British Journal of Haematology 157 (5), 606-614, 2012 | 167 | 2012 |
| Targeting DNA double-strand break repair pathways to improve radiotherapy response M Toulany Genes 10 (1), 25, 2019 | 140 | 2019 |
| Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity M Toulany, M Baumann, HP Rodemann Molecular Cancer Research 5 (8), 863-872, 2007 | 139 | 2007 |
| Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS M Toulany, K Dittmann, M Baumann, HP Rodemann Radiotherapy and oncology 74 (2), 117-129, 2005 | 114 | 2005 |
| The NFĸB pathway inhibitors Bay 11-7082 and parthenolide induce programmed cell death in anucleated erythrocytes M Ghashghaeinia, M Toulany, M Saki, D Bobbala, B Fehrenbacher, ... Cellular Physiology and Biochemistry 27 (1), 45-54, 2011 | 106 | 2011 |
| Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro J Mihatsch, M Toulany, PM Bareiss, S Grimm, C Lengerke, R Kehlbach, ... Radiotherapy and Oncology 99 (3), 300-306, 2011 | 82 | 2011 |
| Age sensitivity of NFκB abundance and programmed cell death in erythrocytes induced by NFκB inhibitors M Ghashghaeinia, JC Cluitmans, M Toulany, M Saki, M Köberle, E Lang, ... Cellular Physiology and Biochemistry 32 (4), 801-813, 2013 | 78 | 2013 |
| Impact of oncogenic K-RASon YB-1 phosphorylation induced by ionizing radiation M Toulany, TA Schickfluß, W Eicheler, R Kehlbach, B Schittek, ... Breast Cancer Research 13, 1-14, 2011 | 78 | 2011 |
| The farnesyl transferase inhibitor lonafarnib inhibits mTOR signaling and enforces sorafenib-induced apoptosis in melanoma cells H Niessner, D Beck, T Sinnberg, K Lasithiotakis, E Maczey, J Gogel, ... Journal of investigative dermatology 131 (2), 468-479, 2011 | 76 | 2011 |
| PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro M Toulany, K Dittmann, B Fehrenbacher, M Schaller, M Baumann, ... DNA repair 7 (10), 1746-1756, 2008 | 75 | 2008 |
| Inhibition of colonic tumor growth by the selective SGK inhibitor EMD638683 ST Towhid, GL Liu, TF Ackermann, N Beier, W Scholz, T Fuchß, ... Cellular physiology and biochemistry 32 (4), 838-848, 2013 | 71 | 2013 |
| Targeting AKT/PKB to improve treatment outcomes for solid tumors M Iida, PM Harari, DL Wheeler, M Toulany Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 819 …, 2020 | 69 | 2020 |
